Rank | Gene Set | Z-score |
---|---|---|
1 | type I interferon signaling pathway (GO:0060337) | 4.98021058 |
2 | cellular response to type I interferon (GO:0071357) | 4.98021058 |
3 | response to type I interferon (GO:0034340) | 4.97616384 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33350524 |
5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.19169806 |
6 | negative regulation of cell killing (GO:0031342) | 4.17657537 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.17657537 |
8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10603785 |
9 | negative regulation of interleukin-12 production (GO:0032695) | 4.05180656 |
10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04806814 |
11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.99641198 |
12 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.95478090 |
13 | negative regulation of viral genome replication (GO:0045071) | 3.94396905 |
14 | regulation of interferon-alpha production (GO:0032647) | 3.83127656 |
15 | immunoglobulin mediated immune response (GO:0016064) | 3.82821065 |
16 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.80104924 |
17 | regulation of chronic inflammatory response (GO:0002676) | 3.56847766 |
18 | positive regulation of interferon-alpha production (GO:0032727) | 3.51054193 |
19 | regulation of regulatory T cell differentiation (GO:0045589) | 3.49992629 |
20 | response to interferon-beta (GO:0035456) | 3.48961298 |
21 | macrophage activation involved in immune response (GO:0002281) | 3.45614829 |
22 | regulation of T cell tolerance induction (GO:0002664) | 3.33617031 |
23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33418371 |
24 | response to peptidoglycan (GO:0032494) | 3.32266531 |
25 | defense response to protozoan (GO:0042832) | 3.32039620 |
26 | response to interferon-alpha (GO:0035455) | 3.30658225 |
27 | positive regulation of defense response to virus by host (GO:0002230) | 3.21743744 |
28 | regulation of antigen processing and presentation (GO:0002577) | 3.20990909 |
29 | cytidine metabolic process (GO:0046087) | 3.19201735 |
30 | cytidine catabolic process (GO:0006216) | 3.19201735 |
31 | cytidine deamination (GO:0009972) | 3.19201735 |
32 | modulation by symbiont of host immune response (GO:0052553) | 3.18267943 |
33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18267943 |
34 | modulation by symbiont of host defense response (GO:0052031) | 3.18267943 |
35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18267943 |
36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18267943 |
37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18267943 |
38 | positive regulation of type 2 immune response (GO:0002830) | 3.17217890 |
39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16679272 |
40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.16324739 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15742971 |
42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.15314886 |
43 | response to protozoan (GO:0001562) | 3.11236978 |
44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10946994 |
45 | myeloid dendritic cell differentiation (GO:0043011) | 3.09789469 |
46 | detection of other organism (GO:0098543) | 3.08902686 |
47 | T cell migration (GO:0072678) | 3.07207714 |
48 | lymphocyte chemotaxis (GO:0048247) | 3.03986112 |
49 | germinal center formation (GO:0002467) | 3.02066378 |
50 | cellular response to interferon-gamma (GO:0071346) | 3.01231636 |
51 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00811888 |
52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99783607 |
53 | NIK/NF-kappaB signaling (GO:0038061) | 2.98633281 |
54 | detection of bacterium (GO:0016045) | 2.97893073 |
55 | T-helper 1 type immune response (GO:0042088) | 2.96529832 |
56 | response to interferon-gamma (GO:0034341) | 2.95715356 |
57 | negative regulation of innate immune response (GO:0045824) | 2.93499105 |
58 | B cell mediated immunity (GO:0019724) | 2.90303716 |
59 | regulation of type 2 immune response (GO:0002828) | 2.86900953 |
60 | interferon-gamma secretion (GO:0072643) | 2.86778630 |
61 | regulation of tolerance induction (GO:0002643) | 2.86213544 |
62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85785091 |
63 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.84639216 |
64 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.84162063 |
65 | myeloid dendritic cell activation (GO:0001773) | 2.83838253 |
66 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.83006396 |
67 | regulation of interleukin-12 production (GO:0032655) | 2.79899883 |
68 | detection of molecule of bacterial origin (GO:0032490) | 2.79368041 |
69 | defense response to virus (GO:0051607) | 2.79022819 |
70 | response to interleukin-15 (GO:0070672) | 2.76080036 |
71 | detection of external biotic stimulus (GO:0098581) | 2.75849094 |
72 | positive regulation of interferon-beta production (GO:0032728) | 2.75819945 |
73 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.75699048 |
74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74858027 |
75 | positive regulation of tolerance induction (GO:0002645) | 2.74034675 |
76 | neutrophil activation involved in immune response (GO:0002283) | 2.73256329 |
77 | cellular response to interferon-beta (GO:0035458) | 2.71071714 |
78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.69671785 |
79 | cellular response to interleukin-15 (GO:0071350) | 2.69631158 |
80 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68811519 |
81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.66966375 |
82 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.66711253 |
83 | negative regulation of T cell mediated immunity (GO:0002710) | 2.66559282 |
84 | regulation of mononuclear cell migration (GO:0071675) | 2.66484513 |
85 | negative regulation of viral process (GO:0048525) | 2.66383933 |
86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66130278 |
87 | eosinophil chemotaxis (GO:0048245) | 2.65365914 |
88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63464367 |
89 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63464367 |
90 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.61035896 |
91 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.60260373 |
92 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.60206294 |
93 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.59794880 |
94 | regulation of T-helper cell differentiation (GO:0045622) | 2.59540912 |
95 | regulation of viral genome replication (GO:0045069) | 2.58923218 |
96 | negative regulation of type I interferon production (GO:0032480) | 2.58129020 |
97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.57186059 |
98 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.57014882 |
99 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.56244395 |
100 | granulocyte activation (GO:0036230) | 2.55709544 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.38382640 |
2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.44530333 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52030333 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.51112987 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.66443413 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60343714 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.51836966 |
8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.07764670 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.05544092 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.75027665 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65704972 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55563127 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42001066 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36471764 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35217820 |
16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25255833 |
17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13963591 |
18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99181011 |
19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96435067 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89244568 |
21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75371501 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 1.73943087 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73405303 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69433934 |
25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67128054 |
26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61097515 |
27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59241028 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56045275 |
29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52845058 |
30 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51784632 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50832375 |
32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43589586 |
33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42591426 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42255763 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42010279 |
36 | MAF_26560356_Chip-Seq_TH1_Human | 1.40985993 |
37 | MYB_26560356_Chip-Seq_TH1_Human | 1.40057263 |
38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38567443 |
39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38449900 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37168060 |
41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35652958 |
42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32033972 |
43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28598409 |
44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28319567 |
45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27582533 |
46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27082951 |
47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25703352 |
48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16441423 |
49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16304842 |
50 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15223914 |
51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14911750 |
52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11283487 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10522508 |
54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10447579 |
55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08699229 |
56 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07499313 |
57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06298814 |
58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05110956 |
59 | MAF_26560356_Chip-Seq_TH2_Human | 1.04565004 |
60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03650125 |
61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01974871 |
62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01256739 |
63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01110629 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00571136 |
65 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99100066 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97781920 |
67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97505161 |
68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97485904 |
69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96988912 |
70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96404899 |
71 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93109158 |
72 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91839662 |
73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91616281 |
74 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89405548 |
75 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87885545 |
76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86949855 |
77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.86944464 |
78 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84875406 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84692326 |
80 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84681851 |
81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82677108 |
82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82243508 |
83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81279081 |
84 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81128195 |
85 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78771481 |
86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77693069 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74831160 |
88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73720545 |
89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72882004 |
90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72868710 |
91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72824114 |
92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.72541294 |
93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72091169 |
94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.71172951 |
95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70786063 |
96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70431496 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69094314 |
98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68726779 |
99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.68132872 |
100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67165537 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.31122283 |
2 | MP0003303_peritoneal_inflammation | 3.64655163 |
3 | MP0009785_altered_susceptibility_to | 3.60090292 |
4 | MP0001835_abnormal_antigen_presentation | 3.59931277 |
5 | MP0006082_CNS_inflammation | 3.47576675 |
6 | MP0005671_abnormal_response_to | 3.27867430 |
7 | MP0003436_decreased_susceptibility_to | 3.27808683 |
8 | MP0002148_abnormal_hypersensitivity_rea | 3.12300419 |
9 | MP0005387_immune_system_phenotype | 2.91295035 |
10 | MP0001790_abnormal_immune_system | 2.91295035 |
11 | MP0005000_abnormal_immune_tolerance | 2.77733468 |
12 | MP0005025_abnormal_response_to | 2.70541555 |
13 | MP0000685_abnormal_immune_system | 2.65515738 |
14 | MP0002419_abnormal_innate_immunity | 2.46291789 |
15 | MP0001800_abnormal_humoral_immune | 2.45516202 |
16 | MP0002723_abnormal_immune_serum | 2.34556195 |
17 | MP0002452_abnormal_antigen_presenting | 2.20713292 |
18 | MP0003300_gastrointestinal_ulcer | 2.13552969 |
19 | MP0002139_abnormal_hepatobiliary_system | 2.13242349 |
20 | MP0001533_abnormal_skeleton_physiology | 2.11102659 |
21 | MP0004510_myositis | 2.05365491 |
22 | MP0002420_abnormal_adaptive_immunity | 1.98438992 |
23 | MP0001819_abnormal_immune_cell | 1.98344884 |
24 | MP0003195_calcinosis | 1.93564272 |
25 | MP0001845_abnormal_inflammatory_respons | 1.90159251 |
26 | MP0010155_abnormal_intestine_physiology | 1.88433907 |
27 | MP0003075_altered_response_to | 1.87251905 |
28 | MP0009764_decreased_sensitivity_to | 1.83226569 |
29 | MP0004947_skin_inflammation | 1.82563638 |
30 | MP0005058_abnormal_lysosome_morphology | 1.80223961 |
31 | MP0009333_abnormal_splenocyte_physiolog | 1.74842167 |
32 | MP0003172_abnormal_lysosome_physiology | 1.74419281 |
33 | MP0008469_abnormal_protein_level | 1.73922280 |
34 | MP0002405_respiratory_system_inflammati | 1.70814368 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.68890222 |
36 | MP0009840_abnormal_foam_cell | 1.66404914 |
37 | MP0003806_abnormal_nucleotide_metabolis | 1.65040784 |
38 | MP0003763_abnormal_thymus_physiology | 1.54264520 |
39 | MP0005310_abnormal_salivary_gland | 1.48526559 |
40 | MP0006054_spinal_hemorrhage | 1.48385535 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.45934607 |
42 | MP0000716_abnormal_immune_system | 1.43461247 |
43 | MP0001853_heart_inflammation | 1.37696370 |
44 | MP0005166_decreased_susceptibility_to | 1.36886480 |
45 | MP0000343_altered_response_to | 1.35845496 |
46 | MP0000604_amyloidosis | 1.34291306 |
47 | MP0005451_abnormal_body_composition | 1.29788651 |
48 | MP0003866_abnormal_defecation | 1.29484689 |
49 | MP0003448_altered_tumor_morphology | 1.27731186 |
50 | MP0005464_abnormal_platelet_physiology | 1.23924015 |
51 | MP0003690_abnormal_glial_cell | 1.23396978 |
52 | MP0002398_abnormal_bone_marrow | 1.23358490 |
53 | MP0005164_abnormal_response_to | 1.21962776 |
54 | MP0003183_abnormal_peptide_metabolism | 1.20165576 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.13478666 |
56 | MP0002998_abnormal_bone_remodeling | 1.12650420 |
57 | MP0002254_reproductive_system_inflammat | 1.11384644 |
58 | MP0004883_abnormal_blood_vessel | 1.10144404 |
59 | MP0000689_abnormal_spleen_morphology | 1.09069692 |
60 | MP0000858_altered_metastatic_potential | 1.08426265 |
61 | MP0009763_increased_sensitivity_to | 1.07981843 |
62 | MP0003045_fibrosis | 1.07756533 |
63 | MP0002933_joint_inflammation | 1.06071287 |
64 | MP0002429_abnormal_blood_cell | 1.05392361 |
65 | MP0002277_abnormal_respiratory_mucosa | 1.02347554 |
66 | MP0002332_abnormal_exercise_endurance | 1.02042670 |
67 | MP0005390_skeleton_phenotype | 0.98564542 |
68 | MP0002722_abnormal_immune_system | 0.98556502 |
69 | MP0001501_abnormal_sleep_pattern | 0.96131278 |
70 | MP0002166_altered_tumor_susceptibility | 0.95730972 |
71 | MP0001542_abnormal_bone_strength | 0.92461839 |
72 | MP0005365_abnormal_bile_salt | 0.90181038 |
73 | MP0005360_urolithiasis | 0.88953679 |
74 | MP0002693_abnormal_pancreas_physiology | 0.87137761 |
75 | MP0001873_stomach_inflammation | 0.82877884 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.79991351 |
77 | MP0009765_abnormal_xenobiotic_induced | 0.78791691 |
78 | MP0005319_abnormal_enzyme/_coenzyme | 0.77334993 |
79 | MP0001545_abnormal_hematopoietic_system | 0.77059812 |
80 | MP0005397_hematopoietic_system_phenotyp | 0.77059812 |
81 | MP0000920_abnormal_myelination | 0.74374422 |
82 | MP0005165_increased_susceptibility_to | 0.73212867 |
83 | MP0001663_abnormal_digestive_system | 0.72986363 |
84 | MP0008004_abnormal_stomach_pH | 0.72563021 |
85 | MP0005023_abnormal_wound_healing | 0.72380642 |
86 | MP0003252_abnormal_bile_duct | 0.69533366 |
87 | MP0009643_abnormal_urine_homeostasis | 0.69528759 |
88 | MP0002006_tumorigenesis | 0.69494037 |
89 | MP0003453_abnormal_keratinocyte_physiol | 0.68296136 |
90 | MP0003795_abnormal_bone_structure | 0.67315484 |
91 | MP0008874_decreased_physiological_sensi | 0.66423742 |
92 | MP0008260_abnormal_autophagy | 0.65845868 |
93 | MP0002136_abnormal_kidney_physiology | 0.65693015 |
94 | MP0000249_abnormal_blood_vessel | 0.63977816 |
95 | MP0000609_abnormal_liver_physiology | 0.63340855 |
96 | MP0000703_abnormal_thymus_morphology | 0.62784913 |
97 | MP0003879_abnormal_hair_cell | 0.62368825 |
98 | MP0000465_gastrointestinal_hemorrhage | 0.62303440 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61295659 |
100 | MP0009278_abnormal_bone_marrow | 0.60753413 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Orchitis (HP:0100796) | 5.02620853 |
2 | Retrobulbar optic neuritis (HP:0100654) | 4.99802051 |
3 | Optic neuritis (HP:0100653) | 4.99802051 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.91146095 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.91146095 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.91146095 |
7 | Myositis (HP:0100614) | 4.76912305 |
8 | Eczematoid dermatitis (HP:0000976) | 4.43420691 |
9 | Abnormality of macrophages (HP:0004311) | 4.42536749 |
10 | Recurrent bacterial skin infections (HP:0005406) | 4.23714916 |
11 | Stomatitis (HP:0010280) | 4.22874805 |
12 | Systemic lupus erythematosus (HP:0002725) | 4.01002085 |
13 | Recurrent abscess formation (HP:0002722) | 4.00543227 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80336405 |
15 | Pulmonary infiltrates (HP:0002113) | 3.55023159 |
16 | Mediastinal lymphadenopathy (HP:0100721) | 3.45858885 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.40128035 |
18 | Gastrointestinal infarctions (HP:0005244) | 3.38234820 |
19 | Vasculitis (HP:0002633) | 3.25642632 |
20 | Keratoconjunctivitis sicca (HP:0001097) | 3.25123383 |
21 | Abnormality of T cell number (HP:0011839) | 3.22210494 |
22 | Recurrent fungal infections (HP:0002841) | 3.20599402 |
23 | T lymphocytopenia (HP:0005403) | 3.17986759 |
24 | Hemoptysis (HP:0002105) | 3.16089675 |
25 | Recurrent skin infections (HP:0001581) | 3.11379989 |
26 | Keratoconjunctivitis (HP:0001096) | 3.10136289 |
27 | Dysostosis multiplex (HP:0000943) | 3.05381628 |
28 | Autoimmune hemolytic anemia (HP:0001890) | 3.02415204 |
29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01110390 |
30 | Vacuolated lymphocytes (HP:0001922) | 2.98319075 |
31 | Meningitis (HP:0001287) | 2.93639401 |
32 | Increased IgM level (HP:0003496) | 2.93028878 |
33 | Obstructive lung disease (HP:0006536) | 2.89036043 |
34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.89036043 |
35 | Hematochezia (HP:0002573) | 2.87482720 |
36 | Autoimmune thrombocytopenia (HP:0001973) | 2.82397595 |
37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74886725 |
38 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74886725 |
39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74886725 |
40 | Gangrene (HP:0100758) | 2.74630638 |
41 | Loss of speech (HP:0002371) | 2.72236867 |
42 | Encephalitis (HP:0002383) | 2.71088495 |
43 | Arterial thrombosis (HP:0004420) | 2.69014116 |
44 | Pulmonary embolism (HP:0002204) | 2.61753744 |
45 | Glomerulonephritis (HP:0000099) | 2.61015052 |
46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60493879 |
47 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60493879 |
48 | Mucopolysacchariduria (HP:0008155) | 2.59462680 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59462680 |
50 | Joint swelling (HP:0001386) | 2.55403725 |
51 | Abnormality of the pleura (HP:0002103) | 2.54041493 |
52 | Hypergammaglobulinemia (HP:0010702) | 2.44249308 |
53 | Purpura (HP:0000979) | 2.42525454 |
54 | Recurrent viral infections (HP:0004429) | 2.40839213 |
55 | Anorexia (HP:0002039) | 2.39825951 |
56 | Episodic fever (HP:0001954) | 2.38544198 |
57 | Abnormality of the pericardium (HP:0001697) | 2.38314853 |
58 | Abnormality of T cells (HP:0002843) | 2.36413354 |
59 | Leukocytosis (HP:0001974) | 2.34914003 |
60 | Pustule (HP:0200039) | 2.32542916 |
61 | Progressive neurologic deterioration (HP:0002344) | 2.31719069 |
62 | Gingivitis (HP:0000230) | 2.31325206 |
63 | Complement deficiency (HP:0004431) | 2.29189493 |
64 | Chest pain (HP:0100749) | 2.28747155 |
65 | Recurrent bronchitis (HP:0002837) | 2.27011580 |
66 | Increased cerebral lipofuscin (HP:0011813) | 2.25747382 |
67 | Increased serum ferritin (HP:0003281) | 2.24594708 |
68 | Interstitial pulmonary disease (HP:0006530) | 2.23670409 |
69 | Gingival bleeding (HP:0000225) | 2.22268814 |
70 | Petechiae (HP:0000967) | 2.22153036 |
71 | Increased IgE level (HP:0003212) | 2.18876366 |
72 | Acne (HP:0001061) | 2.17735898 |
73 | Urticaria (HP:0001025) | 2.16907433 |
74 | Disinhibition (HP:0000734) | 2.16380550 |
75 | Eosinophilia (HP:0001880) | 2.14924316 |
76 | Amyloidosis (HP:0011034) | 2.09870718 |
77 | Abnormality of iron homeostasis (HP:0011031) | 2.09349583 |
78 | Peritonitis (HP:0002586) | 2.08724901 |
79 | Polyneuropathy (HP:0001271) | 2.08715437 |
80 | IgG deficiency (HP:0004315) | 2.06502172 |
81 | Malnutrition (HP:0004395) | 2.06017911 |
82 | Chronic diarrhea (HP:0002028) | 2.02013621 |
83 | Keratitis (HP:0000491) | 1.99856503 |
84 | Mutism (HP:0002300) | 1.99344002 |
85 | Glomerulopathy (HP:0100820) | 1.97576655 |
86 | Vertigo (HP:0002321) | 1.97429096 |
87 | Basal ganglia calcification (HP:0002135) | 1.97311704 |
88 | Granulocytopenia (HP:0001913) | 1.91317234 |
89 | Abnormality of complement system (HP:0005339) | 1.89421365 |
90 | Nuclear cataract (HP:0100018) | 1.89359062 |
91 | Increased CSF protein (HP:0002922) | 1.88836911 |
92 | Arthralgia (HP:0002829) | 1.86979003 |
93 | Chronic otitis media (HP:0000389) | 1.86866074 |
94 | Abnormality of T cell physiology (HP:0011840) | 1.85653063 |
95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85587161 |
96 | Thyroiditis (HP:0100646) | 1.84793575 |
97 | Abnormality of eosinophils (HP:0001879) | 1.84038272 |
98 | Parakeratosis (HP:0001036) | 1.83531905 |
99 | Abnormality of the endocardium (HP:0004306) | 1.82605850 |
100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82183814 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 3.74325577 |
2 | TYK2 | 3.55121534 |
3 | RIPK4 | 3.13341171 |
4 | MAP4K1 | 2.89490368 |
5 | TBK1 | 2.68148779 |
6 | IKBKE | 2.58386046 |
7 | MAP3K14 | 2.49006864 |
8 | ERN1 | 2.46051386 |
9 | GRK7 | 2.39062771 |
10 | IRAK4 | 2.36881208 |
11 | BLK | 2.31078530 |
12 | IRAK3 | 2.27827459 |
13 | JAK1 | 2.20803885 |
14 | JAK3 | 2.19127784 |
15 | CSK | 2.10882109 |
16 | IKBKB | 2.02366278 |
17 | MAP3K3 | 1.92097139 |
18 | FRK | 1.84433490 |
19 | TAOK3 | 1.69254593 |
20 | ZAP70 | 1.67174352 |
21 | RIPK1 | 1.65632514 |
22 | ADRBK2 | 1.59478948 |
23 | BMPR2 | 1.58517992 |
24 | TNK2 | 1.54956249 |
25 | MATK | 1.53626204 |
26 | FES | 1.53495412 |
27 | SYK | 1.52302257 |
28 | FGFR3 | 1.50503088 |
29 | FGFR4 | 1.44647254 |
30 | KIT | 1.41704975 |
31 | FGR | 1.34544768 |
32 | MAP2K3 | 1.33219272 |
33 | MAP3K11 | 1.30590147 |
34 | TGFBR2 | 1.30174558 |
35 | JAK2 | 1.28059998 |
36 | LYN | 1.25812054 |
37 | TAOK2 | 1.20836572 |
38 | LCK | 1.20608790 |
39 | MAP3K13 | 1.19913100 |
40 | EPHB1 | 1.17317602 |
41 | ITK | 1.12252991 |
42 | TAOK1 | 1.12177059 |
43 | MAP3K1 | 1.11095679 |
44 | GRK6 | 1.09520125 |
45 | DDR2 | 1.07166859 |
46 | DAPK2 | 1.06020213 |
47 | HCK | 1.06014838 |
48 | CDC42BPA | 1.05938802 |
49 | BTK | 0.97510601 |
50 | IRAK1 | 0.95691430 |
51 | HIPK2 | 0.93837595 |
52 | NME2 | 0.93614417 |
53 | CSF1R | 0.93115760 |
54 | EPHA3 | 0.91067428 |
55 | MAP2K6 | 0.84832015 |
56 | STK10 | 0.78236726 |
57 | CHUK | 0.76881847 |
58 | MOS | 0.75610212 |
59 | PRPF4B | 0.71330051 |
60 | PDK1 | 0.70764265 |
61 | NLK | 0.70118633 |
62 | MAPKAPK3 | 0.69369967 |
63 | PRKD2 | 0.69351096 |
64 | PIM2 | 0.68571765 |
65 | MARK3 | 0.64499203 |
66 | PRKCQ | 0.63976693 |
67 | GRK5 | 0.63034348 |
68 | PTK2B | 0.61091175 |
69 | ABL2 | 0.57941649 |
70 | TLK1 | 0.56184994 |
71 | CAMKK2 | 0.56134066 |
72 | IRAK2 | 0.53259218 |
73 | MST4 | 0.50075450 |
74 | PDPK1 | 0.49789684 |
75 | TEC | 0.48758250 |
76 | MAPK11 | 0.47406094 |
77 | FYN | 0.46294841 |
78 | PIM1 | 0.45629314 |
79 | MAP3K5 | 0.42772960 |
80 | ACVR1B | 0.42751490 |
81 | MAPK7 | 0.42347735 |
82 | TESK2 | 0.41778293 |
83 | TRPM7 | 0.40481473 |
84 | ABL1 | 0.39140796 |
85 | MAPKAPK2 | 0.37089142 |
86 | KDR | 0.36925957 |
87 | SIK3 | 0.36516381 |
88 | MAP3K2 | 0.35794678 |
89 | PRKCD | 0.34990768 |
90 | FER | 0.31614596 |
91 | MAP3K12 | 0.31091921 |
92 | INSR | 0.30294281 |
93 | PRKAA2 | 0.29618246 |
94 | IGF1R | 0.29577827 |
95 | EGFR | 0.28968833 |
96 | STK24 | 0.28915794 |
97 | GRK1 | 0.28646712 |
98 | FGFR2 | 0.27823849 |
99 | PTK6 | 0.27815755 |
100 | PRKCH | 0.27741382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.31645028 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.01046213 |
3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92737750 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.92662334 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.70739763 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48838072 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.47551211 |
8 | Asthma_Homo sapiens_hsa05310 | 2.44496496 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.39982476 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38233557 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31174919 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29964682 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.28347908 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14830342 |
15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.14335217 |
16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.07404965 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04152000 |
18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04019150 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95749297 |
20 | Malaria_Homo sapiens_hsa05144 | 1.89678370 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89162595 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.77045767 |
23 | Measles_Homo sapiens_hsa05162 | 1.76886165 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.73712964 |
25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70797970 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.64359957 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57905891 |
28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.56073241 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.54804934 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53610229 |
31 | Lysosome_Homo sapiens_hsa04142 | 1.50493679 |
32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47124390 |
33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42849329 |
34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39345001 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37315584 |
36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34954460 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29283738 |
38 | Hepatitis C_Homo sapiens_hsa05160 | 1.20668335 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18462686 |
40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16075479 |
41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12249340 |
42 | Phagosome_Homo sapiens_hsa04145 | 1.10628280 |
43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07077230 |
44 | Salmonella infection_Homo sapiens_hsa05132 | 1.05442341 |
45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95393031 |
46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90773130 |
47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90660064 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88823745 |
49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85719513 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85159181 |
51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78062782 |
52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76480332 |
53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74649190 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73692809 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.70891614 |
56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68817691 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.68489965 |
58 | Prion diseases_Homo sapiens_hsa05020 | 0.67555664 |
59 | Apoptosis_Homo sapiens_hsa04210 | 0.66034094 |
60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54612892 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51937790 |
62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50149811 |
63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49871862 |
64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48200060 |
65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47376531 |
66 | Mineral absorption_Homo sapiens_hsa04978 | 0.46816009 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45157362 |
68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42431830 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41961201 |
70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41895705 |
71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41797828 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.41335559 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37790535 |
74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37085234 |
75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36249327 |
76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35460218 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.35233228 |
78 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34693168 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34028933 |
80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31102162 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.30358883 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29121768 |
83 | ABC transporters_Homo sapiens_hsa02010 | 0.27105250 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25248448 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25082349 |
86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21894956 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21451173 |
88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20994708 |
89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20400180 |
90 | Platelet activation_Homo sapiens_hsa04611 | 0.18266326 |
91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.17450852 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17273786 |
93 | Peroxisome_Homo sapiens_hsa04146 | 0.15213281 |
94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.14957552 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13818519 |
96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.12684967 |
97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.12075840 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.11816455 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11296984 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10649058 |